USPH director reports 4,000-share purchase at $69 (Form 4)
U.S. Physical Therapy, Inc. (USPH) director reported a purchase of company stock.
Rhea-AI Filing Summary
U.S. Physical Therapy, Inc. (USPH) director reported a purchase of company stock. On 11/20/2025, the reporting person bought 4,000 shares of common stock at a price of $69 per share, coded as a purchase transaction on a Form 4 filing. After this trade, the director beneficially owns 24,786 shares directly.
This total includes 471 restricted shares that were granted under the company’s Amended and Restated 2003 Stock Incentive Plan. These restricted shares will fully vest on March 6, 2026, provided she continues to serve on the Board of Directors through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,000 | $69.00 | $276K |
Footnotes (1)
- F1. Includes 471 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. These shares will fully vest on March 6, 2026 if she remains as a member of the Board of Directors of the Company on that date.
FAQ
What insider transaction did USPH report on this Form 4?
The Form 4 reports that a director of U.S. Physical Therapy, Inc. (USPH) purchased 4,000 shares of common stock on 11/20/2025 at $69 per share.
What was the transaction code used in the USPH Form 4 filing?
The transaction is coded as P, indicating a purchase of common stock.
Is the USPH Form 4 filed for one or multiple reporting persons?
The filing is indicated as a Form filed by One Reporting Person, not a joint filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.